Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

A CVS spokesperson said the Emory collaboration is the first time MinuteClinic has expanded into primary care services in ...

CVS Pharmacy and MinuteClinic are offering measles immunizations at over 875 locations across Texas with nearly 60 cases ...

A reescalating battle between pharmaceutical companies and pharmacy benefit managers is brewing in Washington, D.C., as ...

Principal Securities Inc. grew its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.2% during the fourth ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...